Category Archives: Tms

- Positive results from two studies reconfirm safety and efficacy of Focal One -

- Company to host conference call and webcast today, Wednesday, May 17that 8:30 am EDT -

LYON, France, May 17, 2023 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced today unaudited financial results for the first quarter ended March 31, 2023.

"After achieving record results in the fourth quarter of 2022, we continued to see growing demand through the first quarter of 2023, with our strongest Q1 revenue performance on record," said Ryan Rhodes, Chief Executive Officer of EDAP. "We placed seven Focal One units, including six equipment sales and one operating lease. Based upon the positive feedback from urologists, particularly at this year's recent EAU & AUA meetings, we expect momentum for the Focal One platform to continue throughout 2023, driven by our state-of-the-art technology, our positive clinical outcomes demonstrating excellent oncologic control, and our world-class sales and customer support team."

"Beyond our commercial performance, we also announced positive results from two clinical studies utilizing Focal One, both conducted at leading academic urology centers. Results from these studies clearly demonstrate the safety, efficacy, and benefits of Focal One that support both continued growth and increased utilization of the technology. As Focal One continues to grow, we are also making commercial progress in other areas. We recently received approval of ExactVuTM micro-ultrasound in Japan, representing a significant regulatory milestone for EDAP that introduces this innovative platform to the world's second largest medical device market. As we continue to invest in expanding both clinical and commercial activities to drive bottom line performance, we maintain a strong cash position to support both short and long-term growth."

Business Update:

First Quarter 2023 Results

Total revenue for the first quarter 2023 was EUR 14.8 million (USD 15.9 million), an increase of 13.8% as compared to total revenue of EUR 13.0 million (USD 14.5 million) for the same period in 2022.

Total revenue in the HIFU business for the first quarter 2023 was EUR 5.3 million (USD 5.7 million), an increase of 39.5% as compared to EUR 3.8 million (USD 4.3 million) for the first quarter of 2022. The increase was driven by six Focal One units sold in the first quarter 2023 versus four units sold in the first quarter 2022.

Total revenue in the LITHO business for the first quarter 2023 was EUR 2.8 million (USD 3.0 million), as compared to EUR 2.2 million (USD 2.5 million) for the first quarter of 2022. The improvement was driven by four lithotripsy unit sold in the first quarter of 2023 as compared to one unit sold in the first quarter of 2022.

Total revenue in the Distribution business for the first quarter 2023 was EUR 6.8 million (USD 7.3 million), as compared to EUR 7.0 million (USD 7.8 million) for the first quarter of 2022. The decrease was driven primarily by eight ExactVu units sold during the first quarter of 2023 as compared to nine units sold during the first quarter of 2022.

Gross profit for the first quarter 2023 was EUR 6.0 million (USD 6.5 million), compared to EUR 5.8 million (USD 6.4 million) for the year-ago period. Gross profit margin on net sales was 40.8% in the first quarter of 2023, compared to 44.3% in the year-ago period. The decrease in gross profit rate year-over-year was primarily due to investments in service and applications in the U.S.

Operating expenses were EUR 12.6 million (USD 13.6 million) for the first quarter of 2023, compared to EUR 5.9 million (USD 6.6 million) for the same period in 2022. The significant increase in operating expenses is mainly due to the ongoing build-out of the U.S. team and commercial infrastructure, and non-recurring expenses linked to the leadership succession plan.

Operating loss for the first quarter of 2023 was EUR 6.6 million (USD 7.1 million), compared to an operating loss of EUR 0.1 million (USD 0.1 million) in the first quarter of 2022.

Net loss for the first quarter of 2023 was EUR 7.5 million (USD 8.1 million), or EUR 0.2 per diluted share, as compared to net income of EUR 0.4 million (USD 0.4 million), or EUR 0.01 per diluted share in the year-ago period.

As of March 31, 2023, the company held cash and cash equivalents of EUR 58.3 million (USD 63.4 million) as compared to EUR 63.1 million (USD 67.5 million) as of December 31, 2022.

Conference Call

A conference call and webcast to discuss first quarter 2023 financial results will be hosted by Ryan Rhodes, Chief Executive Officer, Franois Dietsch, Chief Financial Officer and Ken Mobeck, Chief Financial Officer of the U.S. subsidiary, today Wednesday, May 17th, 2023 at 8:30am EDT. Please refer to the information below for conference call dial-in information and webcast registration.

About the Endo-HIFU-R1 Phase 2 Study

The Endo-HIFU-R1 Phase 2 study was designed and conducted to evaluate the safety and efficacy of therapeutic high-Intensity focused ultrasound (HIFU) for the treatment of rectal endometriosis with EDAP's Focal One Robotic HIFU device. At six-months follow up, of the 60 patients enrolled and treated with Focal One HIFU across four centers in France between August 2020 and March 2022, 96.7% demonstrated positive safety with no or non-significant adverse events (Clavien 1), 3.3% presented Clavien 2 complications and zero patients presented Clavien 3 complications. Additional endpoints included evaluation of the effect of HIFU treatment on endometriosis symptoms and Quality of Life (QoL). A significant decrease in endometriosis symptom level (acute pelvic pain, dyspareunia, diarrhea, constipation, rectal bleeding, false urges, tenesmus, rectal spams, posterior pelvic pain and asthenia) and an improvement in almost all evaluated QoL criteria (physical functioning, role limitation due to emotional problems, energy - fatigue, emotional well-being, social functioning, bodily pain, general health, and on physical and mental global score components) were observed at the first post-treatment evaluation at one month, and those benefits were maintained at three and six months following HIFU treatment. The study also blindly evaluated the evolution of nodule volume via MRI, with a significant reduction of the volume of lesions observed at six months. Results from the study were presented by study coordinator, Pr. Gil Dubernard of Croix Rousse University Hospital (Lyon, France) at the Paris Sant Femmes French Congress on Friday, January 27, 2023.

About EDAP TMS SA

A recognized leader in the global therapeutic ultrasound market. EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various pathologies using ultrasound technology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One in Europe and in the U.S. as an answer to all requirements for ideal prostate tissue ablation. With the addition of the ExactVu Micro-Ultrasound device, EDAP TMS is now the only company offering a complete solution from diagnostics to focal treatment of Prostate Cancer. EDAP TMS also produces and distributes other medical equipment including the Sonolith i-move lithotripter and lasers for the treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL). For more information on the Company, please visit http://www.edap-tms.com, us.hifu-prostate.com and http://www.focalone.com.

Forward-Looking Statements

In addition to historical information, this press release contains forward-looking statements within the meaning of applicable federal securities laws, including Section 27A of the U.S. Securities Act of 1933 (the "Securities Act") or Section 21E of the U.S. Securities Exchange Act of 1934, which may be identified by words such as "believe," "can," "contemplate," "could," "plan," "intend," "is designed to," "may," "might," "potential," "objective," "target," "project," "predict," "forecast," "ambition," "guideline," "should," "will," "estimate," "expect" and "anticipate," or the negative of these and similar expressions, which reflect our views about future events and financial performance. Such statements are based on management's current expectations and are subject to a number of risks and uncertainties, including matters not yet known to us or not currently considered material by us, and there can be no assurance that anticipated events will occur or that the objectives set out will actually be achieved. Important factors that could cause actual results to differ materially from the results anticipated in the forward-looking statements include, among others, the clinical status and market acceptance of our HIFU devices and the continued market potential for our lithotripsy and distribution divisions, as well as risks associated with the current worldwide inflationary environment, the uncertain worldwide economic, political and financial environment, geopolitical instability, climate change and pandemics like the COVID 19 pandemic, or other public health crises, and their related impact on our business operations, including their impacts across our businesses or demand for our devices and services.

Other factors that may cause such a difference may also include, but are not limited to, those described in the Company's filings with the Securities and Exchange Commission and in particular, in the sections "Cautionary Statement on Forward-Looking Information" and "Risk Factors" in the Company's Annual Report on Form 20-F.

Forward-looking statements speak only as of the date they are made. Other than required by law, we do not undertake any obligation to update them in light of new information or future developments. These forward-looking statements are based upon information, assumptions and estimates available to us as of the date of this press release, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete.

Company Contact

Blandine Confort

Investor Relations / Legal Affairs

EDAP TMS SA

+33 4 72 15 31 50

bconfort@edap-tms.com

Investor Contact

John Fraunces

LifeSci Advisors, LLC

(917) 355-2395

jfraunces@lifesciadvisors.com

EDAP TMS S.A.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Amounts in thousands of Euros and U.S. Dollars, except per share data)

NOTE: Translated for convenience of the reader to U.S. dollars at the 2023 average three months' noon buying rate of 1 Euro = 1.0777 USD, and 2022 average three months noon buying rate of 1 Euro = 1.1177 USD

EDAP TMS S.A.

UNAUDITED CONSOLIDATED BALANCE SHEETS HIGHLIGHTS

(Amounts in thousands of Euros and U.S. Dollars)

NOTE: Translated for convenience of the reader to U.S. dollars at the noon buying rate of 1 Euro = 1.0872 USD, on March 31, 2023 and at the noon buying rate of 1 Euro = 1.0697 USD, on December 31, 2022.

EDAP TMS S.A.

UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Amounts in thousands of Euros)

(1) including share based compensation expenses for 2,660 thousand of Euros for the three months ended March 31, and 2,103 thousand of Euros for the full year ended December 31, 2022.

NOTE: Translated for convenience of the reader to U.S. dollars at the 2023 average three months' noon buying rate of 1 Euro = 1.0777 USD, and 2022 average twelve months noon buying rate of 1 Euro = 1.0519 USD

EDAP TMS S.A.

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS BY DIVISION

three months ended March 31, 2023

(Amounts in thousands of Euros)

Disclaimer

Edap TMS SA published this content on 17 May 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 May 2023 10:40:10 UTC.

Publicnow 2023

Technical analysis trends EDAP TMS S.A.

Income Statement Evolution

Go here to read the rest:

EDAP TMS S A : Positive results from two studies reconfirm safety ... - Marketscreener.com

Early investments in projects that bring something new have made numerous investors millionaires. One project that has stood out due to the innovation that it will provide is the TMS Network (TMSN).

With prominent tokens such as Shiba Inu (SHIB) on a downtrend, many whales want to diversify their portfolios and have started migrating to this rising presale star. Well discover why this cryptocurrency and its presale have become so popular today.

Recently, Shiba Inu (SHIB) enthusiast LUCIE tweeted about a new development involving the much-discussed Shibarium. The tweet stated that VOR and OoO deployment on the Shibarium beta testnet was now being carried out by the Shiba Inu (SHIB) team. However, Shiba Inu (SHIB) has not recently seen any notable price growth activity.

The Shiba Inu (SHIB) native token value was not affected by this announcement either, as it now has a value of $0.000008633 with a market cap of $5B, a decrease of 1.06% in the past 24 hours. The trading volume for Shiba Inu (SHIB) has also decreased by 14.93% in that same time as it now sits at $126,190,272.

Bearish sentiment can also be seen in the Shiba Inu (SHIB) technical analysis, which shows all moving averages displaying strong sell signals. Even if the Shibarium update helps Shiba Inu (SHIB) see future price growth, experts believe that a $1 valuation may not come anytime soon, causing many whales to migrate to the TMS Network (TMSN) presale.

TMS Network (TMSN) will introduce a one-of-a-kind trading platform built on the Ethereum blockchain, removing the need for an account or FIAT payments. On this platform, users from all over the globe may trade FXs, stocks, and equities just by linking their crypto wallets.

Transparency is at the forefront of TMS Network (TMSN) as it will provide real-time data and analytics to all traders, as well as smart contracts to ensure each trader gets the precise amount of profits. The MT4 and MT5 compatibility bridge will also help users plug in any expert advisors or trading bots into the platform. At the same time, the copy trading feature will allow beginner investors to copy what veteran traders are doing and profit from their choices.

TMS Network (TMSN) will stand out due to all these features, which its native token, TMSN, will power. The presale for this token is now in Stage 3, with a cost of only $0.088. Holding this token will bring access to governance voting rights and becoming a part of the commission revenue sharing model. On TMS Network (TMSN), every TMSN token holder will obtain a commission fee from every trade. As the trade volume grows, so will the commission fees for each TMSN token holder.

TMS Network (TMSN) is a 100% safe investment option thanks to a SolidProof token smart contract audit and a Coinsult team KYC audit. With this in mind, analysts predict that the TMS Network (TMSN) token value will rise to $1.40 by December 2023. If you are interested, sign up for the presale below, and you will also obtain a 50% deposit bonus on any deposit.

Presale: https://presale.tmsnetwork.io

Website: https://tmsnetwork.io

Telegram: https://t.me/TMSNetworkIO

Twitter: https://twitter.com/tmsnetwork_io

See the article here:

Shiba Inu (SHIB) Whale Purchasing Into The TMS Network (TMSN ... - Analytics Insight

The TMS Coils Market 2023 research outlines the key developments in the world market. MarketsandResearch.biz offers the customers a realistic description of the market and assists them in developing expansion plans. It perfectly gives the required details and sophisticated analysis to help build the most acceptable company plan and identify the best way for market players to achieve maximum growth.

Overall market growth can be reached via the current understanding of key drivers, latest situation, various opportunities availability, identifying risks and obstacles, leading market segment, and appropriate analysis of the potential market. In this research, the geographic scope of the worldwide TMS Coils market is shown accurately.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketsandresearch.biz/sample-request/348108

In the research report, different nations are involved:

The regional segment of the research report comprises the market for each region, dominating region of the market, interpretation of the basic historical data of the provincial part, comprehensive analysis of all the regional segments, and contributing factors.

The research contributes to the international market and new participants:

The analysis describes the primary categories of applications:

The analysis describes the primary types of products:

ACCESS FULL REPORT: https://www.marketsandresearch.biz/report/348108/global-tms-coils-market-2023-by-manufacturers-regions-type-and-application-forecast-to-2029

Specified and impactful summary of the market share of each category, the overall rising percentage of each segment, degree of attractiveness of each component, and prominent segment of the market is mentioned in the study.

Study contains:

Customization of the Report:

This report can be customized to meet the clients requirements. Please connect with our sales team (sales@marketsandresearch.biz), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: sales@marketsandresearch.bizWeb: http://www.marketsandresearch.biz

Other Related Reports:

Walk-behind Washing Machine Market Trend Opportunities And Business Growth by 2029

Digital Cockpit Solution Market Growth 2023 and Business Opportunities by 2029

Electrical Axle Drives Market [2023-2029] Key Players And Industry Demand Analysis

Organic Vegetable Puree Market Highlighting Major Drivers and Trends

Lens Center Locator Market Size and Share 2023 to 2029

Read the original post:

TMS Coils Market 2023 Business Growth and Opportunities with Top ... - Cottonwood Holladay Journal

Some cryptocurrencies like Arbitrum (ARB) and Polygon (MATIC) are still reeling from the after-effects of the market slump. Fortunately, TMS Network (TMSN) is going against the tide, and has a significant price rise during the presale.

TMS Network (TMSN) is the first decentralized platform to trade all derivatives without using fiat currency. The state-of-the-art trading platform doesnt require KYC, and doesnt route users orders through TMS Networks (TMSN) trading desk. Transactions on TMS Network (TMSN) are fast, instant, and secure. Users also benefit from the low transaction fee on TMS Network (TMSN). However, the most appealing feature of TMS Network (TMSN) is its commission revenue-sharing model. Here, TMS Network (TMSN) token holders earn a commission from the trading volume on the platform. This additional passive income adds to TMS Network (TMSN) token holders profits. The price of TMS Network (TMSN) has increased from $0.085 to $0.088 recently, and is expected to shoot up again in the coming days. TMS Network (TMSN) has raised $5.63 million during the presale. Investors who buy TMS Networks (TMSN) tokens before the presale ends can get a 50% deposit bonus (limited period offer).

The number of NFT buyers has increased on Polygon (MATIC) due to many collections migrating to the platform. In fact, there has been a 27% increase in Polygon (MATIC) NFT buyers in the last 30 days. Simultaneously, the government of Karnataka, India, has publicly implemented a blockchain network through Polygon (MATIC). LegitDoc by Polygon (MATIC) is a blockchain-based certification platform that will be used by KSDC, a body under Karnatakas Skill Development, Entrepreneurship, and Livelihood Department. This system by Polygon (MATIC) ensures that the certificates given by the establishment will be tamper-proof and authentic. The process is automated to save time and resources. The pilot phase was successful as KSDC granted 180 certificates using Polygons (MATIC) LegitDoc. Despite such positive developments, Polygon (MATIC) token is going downhill. The token lost 14.26% in the last seven days. Polygon (MATIC) is priced at $0.8481 at press time, and is expected to go bearish.

Just when users thought Arbitrum (ARB) was recovering through the two-week gains, the tokens price began to go down once again. Arbitrums (ARB) monthly loss is less than 5%, but the loss for the last week is 15.77% at press time. Furthermore, Arbitrums (ARB) daily active user count fell by 17% in 24 hours. This is not encouraging for the users and developers of Arbitrum (ARB). However, Arbitrum (ARB) posted a Twitter announcement to cheer up the community, and attract more investors. Arbitrum (ARB) outlined a new DAO revenue mechanism where the token holders will earn rewards for the surplus fees accumulated by the platform. This is similar to the revenue commission model by TMS Network (TMSN). According to the post, Arbitrum (ARB) will distribute 3352 ETH worth over $6 million to its DAO members. Nevertheless, the market sentiment for Arbitrum (ARB) is currently negative, as users expect greater losses. We have to wait and see if Arbitrum (ARB) can regain market confidence.

Presale: https://presale.tmsnetwork.io

Website: https://tmsnetwork.io

Telegram: https://t.me/TMSNetworkIO

Twitter: https://twitter.com/tmsnetwork_io

Read more from the original source:

The Top Cryptos To Buy In 2023 - Arbitrum, Polygon and TMS Network - Analytics Insight

Newswise May 12, 2023 Accelerated schedules for repetitive transcranial magnetic stimulation (rTMS) can be offered to patients experiencing treatment-resistant major depressive disorder (MDD), a group of clinicianresearchers and neuroscientists have concluded. The group cautions that such treatment should be proposed only after detailed discussion with patients about acceleration being an alternate form of rTMS scheduling, with documentation of informed consent.

The recommendations are published in a special issue of Harvard Review of Psychiatry (HRP), Interventional Neuropsychiatry and Neuromodulation: An Emerging Subspecialty in Brain Medicine. HRP is published in the Lippincott portfolio by Wolters Kluwer.

Repetitive TMS is a noninvasive therapy in which an electromagnet delivers repeated low-intensity pulses to stimulate the brain. It has been proven safe and effective in numerous clinical trials involving patients whose MDD does not respond to antidepressant medication. Conventionally, rTMS is given once daily 20 to 30 days over four to six weeks. That places great time demands on both patients and clinicians.

Theta burst stimulation treats MDD

The next step in development of rTMS is accelerated schedules in which patients undergo two or more sessions per day, each approximately 30 minutes long, separated by one hour or more. Although this change was just as effective in treating depression as once-daily rTMS, it created a different kind of impracticality and clinical inefficiency, according to Leo Chen, MBBS, MPsych, PhD, FRANZCP, of Monash University/Alfred Health in Melbourne, Australia, and colleagues. These schedules required patients to attend treatment settings for long periods on each treatment day, limiting patient capacity at treatment clinics, they note.

The time burden can be alleviated, at least in part, with a novel approach called theta-burst stimulation (TBS). The most commonly used conventional rTMS protocol delivers electromagnetic pulses at a frequency of 10 Hz, whereas TBS refers to three pulses applied at 50 Hz (gamma frequency), repeated at 5 Hz (theta frequency) intervals. Two or more TBS sessions can be delivered within an hour.

Dr. Chen and his colleagues recently published results from a multicenter randomized, controlled trial in which 10 days of TBS was compared head-to-head with a four week course of conventional rTMS. The two approaches were similar in antidepressant effect and safety. This was the largest study of accelerated TBS in depression to date.

Standardization needed

Accelerated delivery doesnt necessarily mean accelerated response, the authors caution. Some retrospective studies have shown twice-daily rTMS induces antidepressant effects faster than once-daily administration, but the evidence is mixed. One barrier is that studies have varied widely in factors such as the stimulation target, frequency and intensity of stimulation, the duration of breaks between sessions, and the number of pulses applied per session and over a treatment course.

Importantly, though, accelerated rTMSs antidepressant efficacy appears comparable to conventional, once-daily rTMS protocols, Dr. Chens group writes. In addition, studies show that accelerated rTMS protocols are well-tolerated and not associated with serious adverse effects.

As with all therapies, the efficacy, safety, and tolerability of protocols that deviate from those investigated in clinical trials are unknown and should be cautioned against, the researchers continue. The durability and depression relapse patterns following accelerated rTMS remain a recognized knowledge gap.

Read [Accelerated Repetitive Transcranial Magnetic Stimulation to Treat Major Depression: The Past, Present, and Future]

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.

###

About HRP

Harvard Review of Psychiatry is the authoritative source for scholarly reviews and perspectives on a diverse range of important topics in psychiatry. Founded by the Harvard Medical School Department of Psychiatry, the journal is peer-reviewed and not industry sponsored. It is the property of President and Fellows of Harvard College and is affiliated with all of the Departments of Psychiatry at the Harvard teaching hospitals.

Articles encompass all major issues in contemporary psychiatry, including (but not limited to) neuroscience, psychopharmacology, psychotherapy, history of psychiatry, and ethics. In addition to scholarly reviews, perspectives articles, and columns, the journal includes a Clinical Challenge section that presents a case followed by discussion and debate from a panel of experts.

About Wolters Kluwer

Wolters Kluwer (EURONEXT: WKL) is a global leader in professional information, software solutions, and services for the healthcare, tax and accounting, financial and corporate compliance, legal and regulatory, and corporate performance and ESG sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.

Wolters Kluwer reported 2022 annual revenues of 5.5 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 20,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

See the article here:

Accelerated delivery of transcranial magnetic stimulation is safe and effective - Newswise

Crypto market volatility continues to rear during 2023 as early gains made by several established cryptocurrencies such as Polygon (MATIC) and Solana (SOL) have begun to row back in recent weeks, with both coins losing 10% value.

Meanwhile, the brand-new upstart social trading project TMS Network (TMSN) has already seen increases of 1700% during its presale event, which has investors flocking to the platform in their droves after raising $5.6 million so far.

Polygon (MATIC)

Polygon (MATIC) is a seasoned and well-established player in the crypto world with its blockchain optimization solutions. Polygon (MATIC) delivers a powerful, versatile, and quick Ethereum scaling solution that improves Ethereums capability and creates a vast system of connected ERC-20-compatible blockchain networks.

While Polygon (MATIC) can boast plenty of experience, the platform isnt immune to the many and varied threats looming. Indeed, with many new platforms providing similar solutions to Polygons high connectivity, the platform has to keep moving forward to fend off the threat from challengers.

These threats from similar projects are beginning to impact the price of Polygon (MATIC) as the game of cat and mouse continues unabated for supremacy in the layer-2 crypto sector. With Polygon (MATIC) a seasoned veteran in providing proven interoperability and scalability, it would take a brave soul to bet against the coin rebounding, but gains are likely to be held back by the increased competition in the sector.

Solana (SOL)

Since launching its layer-2 sustainable blockchain solution in March 2020, Solana (SOL) has become a key player in the industry by leveraging its unique in-house consensus mechanism. By combining the widely-used proof-of-stake (PoS) protocol with its own proof-of-history (PoH) mechanism, Solana (SOL) is designed to be fast, scalable, and efficient. In short, a one-size solution to the challenges of using Ethereums layer-1 network.

After peaking at $259.96 in November 2021, competition in the layer-2 blockchain sector has increased significantly, with several new chains providing similar functionality to Solana (SOL). Indeed, Solana (SOL) falls foul with its hybrid consensus mechanism, complicating interoperability with other chains. With other blockchain providers overtaking Solana (SOL), analysts expect the current SOL price of $20.38 to remain relatively stagnant compared to its competition.

TMS Network (TMSN)

Cryptocurrency trading is a high-stakes industry, with every trader seeking to gain an edge. TMS Network (TMSN) helps traders achieve this with their pioneering social trading feature elevating the platform to new heights.

TMS Network (TMSN) provides users access to a vast and diverse network of experienced traders in all types of digital assets, sharing insights and strategies to help them navigate the volatile minefield of trading. Users can hop on board shared strategies from successful traders, helping to inform their future trades and learn from the best.

As users develop the skills to negotiate the world of digital trading, they can begin to share their expertise with other users, thus helping TMS Network (TMSN) to cultivate one of the leading online trading communities in the world. As well as daily crypto trades, users can benefit from insight into CFD, Forex, futures, and traditional financial markets.

TMS Network (TMSN) recently launched its presale event at $0.0047. It has gained massive momentum since, with tokens now available at $0.088 in phase 2 of the presale, with more than $5.6 million liquidity already raised. This outstanding early performance and TMS Network (TMSN)s determination to lead innovation in blockchain technology make it an exciting prospect for 2023.

Conclusion

Although crypto markets have seen a rebound in the early months of 2023, prices among established coins remain volatile, with many established coins losing value in recent weeks. TMS Network (TMSN) is an outstanding opportunity for investors to protect themselves against price volatility by locking in their tokens at just $0.088 before sitting back and watching it grow over the coming months.

Presale: https://presale.tmsnetwork.ioWhitepaper: https://tmsnetwork.io/whitepaper.pdfWebsite: https://tmsnetwork.ioTelegram: https://t.me/tmsnetworkioDiscord: https://discord.gg/njA95e7au6

Disclaimer:The statements, views and opinions expressed in this article are solely those of the content provider and do not necessarily represent those of Crypto Reporter. Crypto Reporter is not responsible for the trustworthiness, quality, accuracy of any materials in this article. This article is provided for educational purposes only. Crypto Reporter is not responsible, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with the use of or reliance on any content, goods or services mentioned in this article. Do your research and invest at your own risk.

Go here to read the rest:

Polygon (MATIC) and Solana (SOL) Drop by 10%, While TMS ... - Crypto Reporter

Amidst the bearish cycle in the crypto market, the search for projects with significant growth potential continues. With Curve DAO Token (CRV) and VeChain (VET) in bearish trends and promising paltry gains, TMS Network (TMSN) offers investors all they want in a project. Being a presale token with innovative protocols, TMS Network (TMSN) offers plenty of room for growth. In this article, we will explore why Curve DAO Token (CRV) and VeChain (VET) investors are diversifying their portfolios into TMS Network (TMSN).

Curve DAO Token (CRV) is a decentralized exchange for stablecoins leveraging Automated Market Maker (AMM) to manage liquidity.

Curve DAO Token (CRV) recently deployed the crvUSD stablecoin smart contract on the Ethereum (ETH) mainnet. Since then, there have been more tests on the crvUSD, with observations being made and notes taken.

At the time of writing, Curve DAO Token (CRV) is experiencing a bearish descent, a significant 17% and 23% in the past 7 days and 30 days, respectively. With the bears showing no indication of relaxing their grips on Curve DAO Token (CRV), investors are diversifying their portfolios to a more profitable project, the TMS Network (TMSN).

The versatile layer 1 smart contract platform, VeChain (VET), aims to distribute Internet of Things (IoT) and governance technologies to solve major data hurdles. Through this, VeChain (VET) aims to be the leading provider of real-time and trustless data.

VeChain (VET), through its blockchain technology, is leading the charge in fashion resale platforms. VeChain (VET) hopes to solve challenges such as privacy and data protection, scalability, and transaction charges facing the industry.

In the past 30 days, VeChain (VET) has been in a steep decline of 23%, resulting in a price change to its current price of $0.018. VeChains (VET) bearish decline persisted in the past 24 hours, down by 1.29%. With concerns raging in VeChains (VET) camp among investors, diversification into other profitable projects is in the discussion, with TMS Network (TMSN) a popular option.

TMS Network (TMSN) is aiming to make a statement in the derivatives trading industry by allowing direct payment in crypto for derivatives trading in trading and stock. Interestingly, it hopes to achieve this without users having to ever relinquish their assets or set up an account, only linking their crypto wallets.

Numerous benefits come with investing in TMS Network (TMSN) and holding the token. The TMS Network (TMSN) offers low latency and on-chain analytics, as well as a compatibility bridge through its MT4 and MT5. The compatibility bridge will allow the connection to perks such as trading bots and experts. Furthermore, holders of the native token will receive commissions from the revenue made by the trading platform.

Further perks of investing in TMS Network (TMSN) include enjoying its cheap stage two presale, currently at $0.088. In addition, early investors will receive a 50% bonus that ends on May 12. Additionally, and more importantly, early investors will benefit from the predicted climb in the value of TMS Network (TMSN), which analysts have predicted will reach $2.20 by the end of the year.

TMS Networks (TMSN) aim is the moon, and as early investors, you will get to enjoy the bullish ride. To participate in the TMS Network (TMSN) presale, click on the link below.

Presale: https://presale.tmsnetwork.io

Website: https://tmsnetwork.io

Telegram: https://t.me/TMSNetworkIO

Twitter: https://twitter.com/tmsnetworkio

See the article here:

VeChain (VET) & Curve DAO Token (CRV) Investors Diversify Their ... - Analytics Insight

The cryptosphere is notoriously volatile, which is a great detractor for many investors wary of entering the cryptosphere. However, this volatility is not necessarily a detraction. Tokens like Cardano (ADA) and Dogecoin (DOGE) can plummet and seemingly lose most of their value, only to come back stronger, while TMS Network (TMSN) has compensated for market volatility with its technical prowess.

The world of Cardano (ADA), the third-generation blockchain platform, is nothing if not volatile. Yet, this volatility has never deterred the ardent followers of Cardano (ADA), who remain undeterred by the wild price swings that characterize the crypto markets.

Founded by Ethereum co-founder Charles Hoskinson, Cardano (ADA) was designed with a research-first approach. Its development has been slow and methodical, with every update meticulously peer-reviewed. This has made Cardano (ADA) a steady player in a turbulent market.

In contrast to Cardano (ADA), Dogecoin (DOGE) was born as a joke. The meme coin, emblazoned with the Shiba Inu dog, was never meant to be taken seriously. Yet, Dogecoin (DOGE) has grown into one of the most well-known cryptocurrencies, thanks partly to its embrace of volatility.

Dogecoins (DOGE) price swings have been dramatic, even by crypto standards. Dogecoin (DOGE) has seen astronomical gains spurred by celebrity endorsements and a passionate online community. Yet, it has also experienced sharp declines, reminding investors of the risks inherent in the crypto market.

The wild ride of Dogecoin (DOGE) has captured the imagination of many investors drawn to its unpredictability and potential for massive returns. However, it has also highlighted the speculative nature of the market and the need for careful risk management.

Ultimately, both Cardano (ADA) and Dogecoin (DOGE) offer a study in contrast. Cardano (ADA) s stability and methodical approach stand in stark contrast to Dogecoins (DOGE) wild price swings and unpredictability.

In a world where cryptocurrencies are known for their volatility, TMS Network (TMSN) stands out as an oasis of stability. The secret to its resilience lies in its robust Ethereum-based backbone that ensures smooth operations even during market turbulence.

The bedrock of TMS Network (TMSN) is blockchain technology, a digital ledger system that records every transaction made on the platform. This technology ensures transparency, security, and trust, all of which are critical in navigating the choppy waters of crypto trading.

Moreover, TMS Network (TMSN) harnesses the power of advanced computing capabilities to easily handle massive trading volumes. This scalability ensures that TMS Network (TMSN) can accommodate a growing user base and trading activity without compromising performance.

Additionally, TMS Network (TMSN) has integrated smart contracts into its system. These self-executing contracts, with the terms of the agreement directly written into code, ensure fair and accurate distribution of trading commissions and rewards, regardless of market conditions.

In the stormy seas of cryptocurrency trading, TMS Network (TMSN) serves as a sturdy ship thanks to its strong technical architecture. TMS Network (TMSN) stands as a testament to the power of technology and innovation, proving that with the right tools and systems in place, even the most volatile markets can be navigated with confidence and ease.

During its first phase of presale, TMS Network (TMSN) gained more than $5.6 million in liquidity, and now its second phase of presale is underway, where tokens are available at $0.088.

For more information on the TMS Network (TMSN) presale, follow the links below:

Presale: https://presale.tmsnetwork.io

Whitepaper: https://tmsnetwork.io/whitepaper.pdf

Website: https://tmsnetwork.io

Telegram: https://t.me/tmsnetworkio

Discord: https://discord.gg/njA95e7au6

Go here to read the rest:

As Cardano (ADA) Stumbles And Dogecoin (DOGE) Falters, TMS ... - UseTheBitcoin

Press release, Helsinki, 17 May 2023 at 2 PM (EEST)

Nexstims Quality System and NBS 6 Receive MDR Certification in the EU

Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received certifications for its quality management system and NBS 6 product under MDR (Regulation (EU) 2017/745) in the European Union.

The EU quality management system certificate allows for Nexstim to start marketing and selling the NBS 6 system for the treatment of major depression and chronic neuropathic pain within the European Union. Nexstim announced on April 17, 2023, that it had launched NBS 6 in the United States for the treatment of Major Depressive Disorder (MDD).

The NBS 6 enables Nexstims unique E-field navigated TMS technology to be used more easily than ever before. Part of this new product generation is an easy-to-use, software-guided application and a modular product design that allows for system capabilities to expand over time and be highly customized based on a customers research or treatment interests.

Mikko Karvinen, CEO of Nexstim, comments:

The MDR conformity certification is an important step in the process of launching the NBS 6 and achieving one of our key strategic objectives for 2023. I am proud of the hard work our team has put into making the new software generation available in both the United States and the European Union in such a tight schedule. The EU quality management system certification will benefit us in the long term also by making any future product certification processes more efficient.

The NBS 6 received a great response as we attended and unveiled the product at the Clinical TMS Society Annual Meeting in Colorado Springs, United States earlier this month. We are expecting nothing less from the European market and are excited to continue the promotion work.

Further information is available on the website http://www.nexstim.com, or by contacting:

Mikko Karvinen, CEO+358 50 326 4101mikko.karvinen@nexstim.com

About Nexstim Plc

Nexstim is a Finnish, globally operating growth-oriented medical technology company. Our mission is to enable personalized and effective diagnostics and therapies for challenging brain diseases and disorders.

Nexstim has developed a world-leading non-invasive brain stimulation technology for navigated transcranial magnetic stimulation (nTMS) with highly sophisticated 3D navigation providing accurate and personalized targeting of the TMS to the specific area of the brain.

Nexstims Diagnostics Business focuses on commercialization of the Navigated Brain Stimulation (NBS) system. The NBS system is the only FDA cleared and CE marked navigated TMS system for pre-surgical mapping of the speech and motor cortices of the brain.

Nexstims Therapy Business markets and sells the Navigated Brain Therapy (NBT) system, which is FDA cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States. In Europe, the NBT system is CE marked for the treatment of major depression and chronic neuropathic pain.

Nexstim shares are listed on Nasdaq First North Growth Market Finland.

For more information, please visit http://www.nexstim.com

Read this article:

Nexstim's Quality System and NBS 6 Receive MDR - GlobeNewswire

As we progress into 2023, the crypto industry continues to make inroads into new grounds and is striving to look outside the United States of America in order to gain a foothold elsewhere across Asia and Africa.

In this situation, major cryptocurrencies, Uniswap (UNI) and Shiba Inu (SHIB) have gone under the radar as they continue to struggle for relevance while industry experts have pointed out TMS Network (TMSN) to be the solution to the upheaval.

Uniswap (UNI) was launched in 2018 as a decentralized exchange for ERC-20 tokens and it has now gone on to become the largest decentralized exchange in the crypto world.

Interestingly, Uniswap (UNI) uses liquidity pools in contrast to market makers, this means that individuals and algorithms could provide liquidity in exchange for a percentage of the trading fees generated.

Decentralized exchanges like Uniswap (UNI) are known to be much safer than centralized exchanges like Binance and more resilient to attacks. There are almost a million ERC20 tokens on the Ethereum network, and Uniswap (UNI) is the safest bridge for swapping them which shows that Uniswap (UNI) remains a crucial player in DeFi. Also, as the Ethereum ecosystem grows, Uniswap (UNI) is expected to follow suit.

Uniswap (UNI-USD) is the governance token of the most popular Ethereum-based decentralized exchange but it has been underwater alongside Shiba Inu (SHIB) for some time now while TMS Network (TMSN) continues to surge.

Shiba Inu (SHIB) is a meme coin like Dogecoin which is struggling to regain its former glory and momentum it previously had. Shiba Inu (SHIB) has no unique advantage over other digital currency options and its expected breakthrough was the launch of Shibarium which is a layer-2 scaling solution that would propel its growth.

Although this was expected to be the primary catalyst to take Shiba Inu (SHIB) to the next level, development on the blockchain has been slow despite the fact that more transactions are now on the blockchain and the number of wallets are increasing.

It is well known that Shiba Inu (SHIB) popularity is largely driven by memes and the success of Dogecoin and its price depends mainly on unpredictable hype cycles. All these cause only short-term gains, which has largely made Shiba Inu (SHIB) to be underwater for a long while industry experts now vie for TMS Network (TMSN).

The revolutionary TMS Network (TMSN) has literally taken over the trading industry. Simply put, it is a trading solution that utilizes the Ethereum blockchain to address critical challenges in the crypto industry by enhancing accessibility, efficiency, and security, by cutting out the middleman.

It might come in handy to mention that the TMS Network (TMSN) performs all the listed functions without the use of intermediaries. So it is not a surprise that TMS Network (TMSN) has dominated the crypto space with over 1700% return on investment so far despite the fact that its still in the second phase of its presale.

This has made industry experts predict that there is a strong possibility that TMS Network (TMSN) will continue to experience a

Taking a look at the trio, it is crystal clear that TMS Network (TMSN) is the best option for traders and investors.

Currently, TMS Network (TMSN) is in the second phase of its presale, offering tokens at $0.088. TMS Network (TMSN) has raised over $5.6 million so far as it continues to grow in popularity. Check it out below.

Presale: https://presale.tmsnetwork.io

Website: https://tmsnetwork.io

Telegram: https://t.me/tmsnetwork

See the article here:

Uniswap (UNI) and Shiba Inu (SHIB) Underwater as Crypto Looks ... - The Merkle Hash